AJP - Regulatory, Integrative and Comparative Physiology, Vol 267, Issue 1 84-R88, Copyright © 1994 by American Physiological Society

ARTICLES

Systemic and regional hemodynamics after nitric oxide synthase inhibition: role of a neurogenic mechanism

M. Huang, M. L. Leblanc and R. L. Hester
Department of Physiology and Pediatrics, University of Mississippi Medical Center, Jackson 39216-4505.

The study tested the hypothesis that the increase in blood pressure and decrease in cardiac output after nitric oxide (NO) synthase inhibition with N omega-nitro-L-arginine methyl ester (L-NAME) was partially mediated by a neurogenic mechanism. Rats were anesthetized with Inactin (thiobutabarbital), and a control blood pressure was measured for 30 min. Cardiac output and tissue flows were measured with radioactive microspheres. All measurements of pressure and flows were made before and after NO synthase inhibition (20 mg/kg L-NAME) in a group of control animals and in a second group of animals in which the autonomic nervous system was blocked by 20 mg/kg hexamethonium. In this group of animals, an intravenous infusion of norepinephrine (20-140 ng/min) was used to maintain normal blood pressure. L-NAME treatment resulted in a significant increase in mean arterial pressure in both groups. L-NAME treatment decreased cardiac output approximately 50% in both the intact and autonomic blocked animals (P < 0.05). Autonomic blockade alone had no effect on tissue flows. L-NAME treatment caused a significant decrease in renal, hepatic artery, stomach, intestinal, and testicular blood flow in both groups. These results demonstrate that the increase in blood pressure and decreases in cardiac output and tissue flows after L-NAME treatment are not dependent on a neurogenic mechanism.

This article has been cited by other articles:

				K. P. Patel, Y.-F. Li, and Y. Hirooka Role of Nitric Oxide in Central Sympathetic Outflow Experimental Biology and Medicine, October 1, 2001; 226(9): 814 - 824. [Abstract] [Full Text] [PDF]

				G. J. Crystal, X. Zhou, A. A. Halim, S. Alam, M. El-Orbany, and M. R. Salem Nitric oxide does not modulate whole body oxygen consumption in anesthetized dogs J Appl Physiol, June 1, 1999; 86(6): 1944 - 1949. [Abstract] [Full Text] [PDF]

				J. E. Heavner, B. Shi, and M. Pitkanen Nitric Oxide Synthesis Inhibition Modifies the Cardiotoxicity of Tetracaine and Lidocaine Anesth. Analg., April 1, 1999; 88(4): 717 - 717. [Abstract] [Full Text] [PDF]

				N. Iida Nitric oxide mediates sympathetic vasoconstriction at supraspinal, spinal, and synaptic levels Am J Physiol Heart Circ Physiol, March 1, 1999; 276(3): H918 - H925. [Abstract] [Full Text] [PDF]

				C. Baylis, J. Harvey, B. R. Santmyire, and K. Engels Pressor and Renal Vasoconstrictor Responses to Acute Systemic Nitric Oxide Synthesis Inhibition Are Independent of the Sympathetic Nervous System and Angiotensin II J. Pharmacol. Exp. Ther., February 1, 1999; 288(2): 693 - 698. [Abstract] [Full Text]

				P. Liu, B. Xu, C. E. Hock, R. Nagele, F. F. Sun, and P. Y-K Wong NO modulates P-selectin and ICAM-1 mRNA expression and hemodynamic alterations in hepatic I/R Am J Physiol Heart Circ Physiol, December 1, 1998; 275(6): H2191 - H2198. [Abstract] [Full Text] [PDF]

				Y. Zagvazdin, A. Reiner, I. F. Benter, M. Sander, J. Hansen, and R. G. Victor Central Nervous System Is Not Involved in Initiation of the Pressor Effect of 7-Nitroindazole in Urethane-Anesthetized Rats • Response Hypertension, February 1, 1998; 31 (2): 719 - 720. [Full Text]

				J. K. Shoemaker, J. R. Halliwill, R. L. Hughson, and M. J. Joyner Contributions of acetylcholine and nitric oxide to forearm blood flow at exercise onset and recovery Am J Physiol Heart Circ Physiol, November 1, 1997; 273(5): H2388 - H2395. [Abstract] [Full Text] [PDF]